Gleason 6 Prostate Cancer: Translating Biology Into Population Health.
AUTHORS
Eggener
SE ,
Badani
K ,
Barocas
DA ,
Barrisford
GW ,
Cheng
JS ,
Chin
AI ,
Corcoran
A ,
Epstein
JI ,
George
AK ,
Gupta
GN ,
Hayn
MH ,
Kauffman
EC ,
Lane
B ,
Liss
MA ,
Mirza
M ,
Morgan
TM ,
Moses
K ,
Nepple
KG ,
Preston
M ,
Rais-Bahrami
S ,
Resnick
MJ ,
Siddiqui
MM ,
Silberstein
J ,
Singer
EA ,
Sonn
GA ,
Sprenkle
P ,
Stratton
KL ,
Taylor
J ,
Tomaszewski
J ,
Tollefson
M ,
Vickers
A ,
White
WM ,
Lowrance
WT ,
. The Journal of urology. 2015 4 4; ().
- PMID: 25849602 [PubMed].
ABSTRACT
Gleason 6 (3+3) is the most commonly diagnosed prostate cancer amongst PSA screen-detected men, the most histologically well-differentiated, and associated with the most favorable prognosis. Despite its prevalence, considerable debate exists regarding the genetic features, clinical significance, natural history, metastatic potential and optimal management.
Gleason 6 (3+3) is the most commonly diagnosed prostate cancer amongst PSA screen-detected men, the most histologically well-differentiated, and associated with the most favorable prognosis. Despite its prevalence, considerable debate exists regarding the genetic features, clinical significance, natural history, metastatic potential and optimal management.
Tags: Alumni Publications 2015